Filter
579
Text search:
laboratory
biosafety
Featured
Recommendations
97
New Publications
135
Language
Document type
No document type
272
Guidelines
144
Studies & Reports
59
Manuals
56
Strategic & Response Plan
25
Training Material
8
Fact sheets
6
Situation Updates
5
Resource Platforms
3
Brochures
1
Countries / Regions
India
33
Sierra Leone
17
Latin America and the Carribbean
17
Western and Central Europe
17
Nigeria
16
Africa
16
Global
14
Kenya
12
Ghana
11
Rwanda
11
Eastern Europe
11
Uganda
10
Brazil
10
Liberia
9
Zambia
8
West and Central Africa
8
Ethiopia
7
Mozambique
7
Ukraine
7
East and Southern Africa
7
Philippines
6
Tanzania
6
Bangladesh
6
Angola
6
Middle East and North Africa
6
Congo, Democratic Republic of
5
Nepal
5
South–East Asia Region
5
Russia
5
Syria
4
Namibia
4
Eastern Europe and Central Asia
4
Spain
4
Guinea
3
Guinea-Bissau
3
Pakistan
3
South Africa
3
Malawi
3
Western Pacific Region
3
Tajikistan
3
Burkina Faso
2
Cameroon
2
Germany
2
Myanmar / Burma
2
Senegal
1
USA
1
Saudi Arabia
1
Zimbabwe
1
South Sudan
1
Afghanistan
1
Lebanon
1
Chad
1
China
1
Mauritania
1
Central African Republic
1
Eswatini/ Swaziland
1
North Macedonia
1
Hungary
1
Burundi
1
Colombia
1
Yemen
1
Asia
1
Poland
1
Italy
1
Laos
1
Bulgaria
1
Romania
1
Moldova
1
Slovakia
1
Georgia
1
Vietnam
1
North America
1
Gabon
1
Mauritius
1
Authors & Publishers
Publication Years
Category
Countries
203
Pharmacy & Technologies
59
Clinical Guidelines
50
Key Resources
24
Public Health
21
Women & Child Health
6
Capacity Building
3
Toolboxes
COVID-19
127
TB
104
Ebola & Marburg
60
Rapid Response
60
2.0 Rapid Response
42
AMR
37
NTDs
21
HIV
14
Zika
12
Conflict
9
Polio
8
Caregiver
8
Pharmacy
7
Planetary Health
6
Natural Hazards
4
Specific Hazards
4
Cholera
3
Mental Health
3
Global Health Education
3
Health Financing Toolbox
3
Malaria
2
On 13 August 2024, the Africa Centres for Disease Control (Africa CDC) declared the multi-country mpox outbreak a public health emergency of continental security, with strong recommendations to improve surveillance and vaccine deployment in all AU Member States. On 14 August 2024, the WHO Director-G
...
Guidelines for Diagnosing and Managing Disseminated Histoplasmosis among People Living with HIV
recommended
Histoplasmosis is a disease caused by the fungus Histoplasma capsulatum. This disease is highly endemic in some regions of North America, Central America, and South America and is also reported in certain countries of Asia and Africa. It often affects people with impaired immunity, including people
...
10–21 March 2014
WHO Recommended Surveillance Standards
recommended
Second editon. This document serves only as a guide to good practice and may help to harmonize surveillance activities. The purpose of this manual is to be a handy reference for key elements and contact information for all communicable diseases / syndromes associated with current WHO control program
...
Towards a world free of tuberculosis
Lessons learned from recent public health events such as the COVID-19 pandemic, Ebola virus disease, Zika virus disease outbreaks, and other public health threats, including earthquakes and floods, have highlighted the need for countries to continuously develop, strengthen, and maintain capacities r
...
This protocol provides an approach for public health authorities and investigators at all levels to plan for and conduct investigations of nonseasonal influenza and other emerging respiratory diseases and provides tips and reminders for linking the information from the investigation with risk assess
...
his Inter Action Review report for the COVID-19 outbreak in Mauritius documents and assesses the country’s capacity to respond to the outbreak and identifies the best practices, strengths, gaps and challenges of the national response. Areas requiring improvements or sustained actions have been ide
...
A global Pandemic, Preparedness and Response (RRR) architecture
Supporting the food and agriculture sectors in implementing the Global Action Plan on Antimicrobial Resistance to minimize the impact of antimicrobial resistance
The objective of this project was to list the medical devices required to provide the essential reproductive, maternal, newborn and child health interventions defined by existing WHO guidelines and publications, in order to improve access to these devices in low- and middle-income countries, support
...
This threat assessment addresses the implications of the ongoing Marburg virus disease (MVD) outbreak in
Rwanda for the European Union/European Economic Area (EU/EEA). MVD is a severe disease in humans and,
although uncommon, it has the potential to cause epidemics with significant case fatality.
...
The Infection Prevention and Control (IPC) Assessment Framework (IPCAF) is a tool to support the implementation of the World Health Organization (WHO) Guidelines on core components of IPC programmes at the acute health care facility level. The user should be familiar with the contents of these guide
...
The main objective of this guidance is to provide scientific advice on public health principles and considerations for infection and prevention control of COVID-19 in migrant and refugee reception and detention centres in the European Union and European Economic Area (EU/EEA) and the United Kingdom
...
This course describes the health effects of war, weapons and strategies of violent conflict. Beginning with weapons of mass destruction it then moves on to other weapons and strategies of war such as the use of landmines and mass rape. The course concludes with a number of lessons which give an hist
...
Antimicrobial resistance (AMR) is a global threat that requires urgent collaborative action within and among countries. AMR makes standard treatments ineffective and facilitates the spread of antimicrobial resistant infections rendering communities vulnerable. The Ministry of Health (MOH) and Minist
...
Preparedness planning is essential in order to respond effectively to outbreaks, including single case occurrences of highconsequence infectious diseases (HCID), such as the importation of a viral haemorrhagic fever (VHF) case
ຢາຕ້ານເຊື້ອຈຸລະຊີບ (Antimicrobial medicines) ມີຄວາມສໍາຄັນຫຼາຍຕໍ່ວຽກງານການແພດ, ສາທາລະນະສຸກ, ສຸຂະພາບສັດ ແລະ ການຜະລິດອາຫານ. ເນ
...
Interim rapid response guidance, 10 June 2022.
It includes considerations for certain populations such as patients with mild disease with considerations for community care, patients with moderate to severe disease, sexually active persons, pregnant or breastfeeding women, children and young persons
...
